Retractable Technologies,Inc. (NYSEMKT:RVP) Files An 8-K Other EventsItem 8.01 Other Events.
On January 31, 2017, Retractable Technologies, Inc. filed a petition for a writ of certiorari with the Supreme Court of the United States to review the December 2, 2016 Fifth Circuit Court of Appeals decision in Retractable’s case against Becton, Dickinson and Company.
About Retractable Technologies, Inc. (NYSEMKT:RVP)
Retractable Technologies, Inc. designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe. It also sells the VanishPoint intravenous catheter, the VanishPoint blood collection tube holder and the VanishPoint blood collection set. The PatientSafe syringe reduces the risk of bloodstream infections resulting from catheter hub contamination. Its PatientSafe products include 3mL, 5mL, 10mL, 20mL, 30mL and 60mL syringes, and the PatientSafe Luer cap. Its product designs include retractable needle syringe designs, retractable needle designs and retractable needle dental syringe designs. Retractable Technologies, Inc. (NYSEMKT:RVP) Recent Trading Information
Retractable Technologies, Inc. (NYSEMKT:RVP) closed its last trading session 00.00 at 1.08 with 40,193 shares trading hands.